28 related articles for article (PubMed ID: 123842)
1. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
Ciammaichella A; Solitro A; Torcia L; Arcuri P
Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
[No Abstract] [Full Text] [Related]
2. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
Bompani R; Violi G
Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
[No Abstract] [Full Text] [Related]
3. [Antithrombogenic action of a new extract: 3GS].
Rusconi C; Orlando G
Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
[No Abstract] [Full Text] [Related]
4. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
Marini U; Bastoni F; Gibelli A
Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
[No Abstract] [Full Text] [Related]
5. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
Castello S
Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
[No Abstract] [Full Text] [Related]
6. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
[No Abstract] [Full Text] [Related]
7. Treatment of coronary atherosclerosis.
Gould L
Mod Treat; 1966 May; 3(3):565-78. PubMed ID: 5326566
[No Abstract] [Full Text] [Related]
8. [Effect of Atromid on blood lipids in patients with hyperlipemia].
Baranova LV
Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
[No Abstract] [Full Text] [Related]
9. Heparin, non-heparin glycosaminoglycans, and heparinoids: an overview of their application in atherosclerosis.
Engelberg H
Semin Thromb Hemost; 1991; 17 Suppl 1():5-8. PubMed ID: 1712511
[No Abstract] [Full Text] [Related]
10. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
[No Abstract] [Full Text] [Related]
11. [Pharmacologic therapy of atherosclerosis (I). Current possibilities].
Segarra Domènech J; Santafé Oroz J
Med Clin (Barc); 1983 Nov; 81(17):775-83. PubMed ID: 6361403
[No Abstract] [Full Text] [Related]
12. New concept on atherogenesis and treatment of atherosclerotic diseases.
Shimamoto T
Jpn Heart J; 1972 Nov; 13(6):537-62. PubMed ID: 4631735
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
